US FDA under fire from health advocates in first approval of menthol vape products

Public health advocates expressed disappointment after a recent decision by the US Food and Drug Administration (FDA) to authorise the sale of several menthol vaping products – including two menthol disposable e-cigarettes – made by Njoy, a subsidiary of tobacco giant Altria. Critics of the decision accused the federal agency of failing to protect youth and undermining efforts to end the youth vaping epidemic in the US.

After reviewing the company’s premarket tobacco product applications (PMTAs), the FDA determined that evidence demonstrating these menthol-flavoured products could aid adult smokers in completely switching from traditional cigarettes was sufficient to outweigh the risks associated with youth appeal. The decision marks the first authorisation of non-tobacco-flavoured e-cigarette products by the federal agency.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization